Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IVX.AU
- Price
- 0.09
- Stock movement down
- -0.01 (-6.52%)
- Company name
- Invion Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 7.37M
- Ent value
- 7.75M
- Price/Sales
- 1.99
- Price/Book
- 0.89
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 43.62%
- 1 year return
- -70.34%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-15
DIVIDENDS
IVX.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.99 |
| Price to Book | 0.89 |
| EV to Sales | 2.10 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 85.65M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 850.37K |
| Net receivables | 0.00 |
| Total current assets | 933.20K |
| Goodwill | 0.00 |
| Intangible assets | 8.54M |
| Property, plant and equipment | 20.52K |
| Total assets | 9.49M |
| Accounts payable | 542.80K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.24M |
| Total liabilities | 1.24M |
| Shareholder's equity | 8.25M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.09 |
| Daily high | 0.09 |
| Daily low | 0.08 |
| Daily Volume | 64K |
| All-time high | 54.56 |
| 1y analyst estimate | 0.11 |
| Beta | 0.77 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| IVX.AU | S&P500 | |
| Current price drop from All-time high | -99.84% | -1.22% |
| Highest price drop | -99.86% | -19.00% |
| Date of highest drop | 19 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -99.74% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 301 days | 89 days |
COMPANY DETAILS
Marketcap
7.37M
Marketcap category
Small-cap
Description
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found